Literature DB >> 9402319

Reed-Sternberg cells and the TNF family of receptors/ligands.

K Clodi1, A Younes.   

Abstract

Treatment of cancer with means other than chemo- and radiation therapy becomes more and more important. Through the better understanding of tumor biology approaches towards the cure of cancer interfering with the pathophysiological mechanisms of malignancy can be considered. Hodgkin's disease is a good example for the role of the immune system in cancer. The Reed-Sternberg (RS) cells, malignant cells of Hodgkin's disease (HD), are surrounded by tumor infiltrating lymphocytes (TILs) and still evade immunesurveillance. In this respect the importance of the superfamily of tumor necrosis factor (TNF) receptors and ligands is becoming more and more clear. Ligand-receptor interaction either leads to death or survival signals. Many of these receptors and ligands are expressed by the RS cells and the surrounding lymphocytes. Their expression and function in HD are discussed and future directions for possible therapeutical investigations are proposed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402319     DOI: 10.3109/10428199709059676

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Novel therapies for Hodgkin Lymphoma.

Authors:  John W Sweetenham
Journal:  Ther Adv Hematol       Date:  2010-02

Review 2.  Brentuximab Vedotin in CD30+ Lymphomas.

Authors:  Guilherme Fleury Perini; Barbara Pro
Journal:  Biol Ther       Date:  2013-03-01

Review 3.  Treatment challenges in the management of relapsed or refractory non-Hodgkin's lymphoma - novel and emerging therapies.

Authors:  Mark P Chao
Journal:  Cancer Manag Res       Date:  2013-08-23       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.